|Bid||18.50 x 900|
|Ask||18.74 x 800|
|Day's Range||17.57 - 21.50|
|52 Week Range||2.43 - 22.61|
|Beta (5Y Monthly)||3.11|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Aurora Cannabis (NYSE: ACB) and Tilray (NASDAQ: TLRY) were among a handful of international marijuana producers chosen to participate in a new French medical marijuana experiment. The National Agency for Medicines and Health Products Safety (ANSM) is trialing a small-scale, 18- to 24-month program to supply patients with medical marijuana free of charge. Partnering with a France-based pharmaceutical establishment, producers will supply up to 3,000 patients with free product while complying with pharmaceutical standards, including Good Manufacturing Practices (GMP).
Since then, Tom Brady has made his own case for the moniker, with many rooting for the 43-year-old quarterback to lead the Tampa Bay Buccaneers to victory in Super Bowl LV. Already in 2021, several stocks are making their case to be the Comeback Kid of the year. Tilray (NASDAQ: TLRY) was one of the darlings of the stock market in the late 2010s.
Yahoo Finance’s Alexis Christoforous and Chris Beals, CEO of WM Holding Co., the parent company of Weedmaps, discuss what Democratic control of Congress could mean for the cannabis industry.